Prospective, Randomized, open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine Compared with Midazolam in children admitted to Pediatric Critical Care unit (PICU) at KAMC-NGHA (PROMISE)

drug protocol number
RC11/084
drug sponsor
KAIMRC
drug study
Dexmedetomidine
drug trial site
NGHA-R
drug status
Rejected
drug phase